Enliven Therapeutics, Inc. (ELVN)

Last Closing Price: 29.44 (2026-03-06)

Receiveable Turnover (Annual)

Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable

Enliven Therapeutics, Inc. (ELVN) Receiveable Turnover data is not available.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
--
$-103.69M
--
--
$119.66M
$-119.66M
$15.96M
$-103.69M
$-103.69M
$-103.69M
$-103.69M
$-103.69M
$-103.69M
$-119.66M
$-119.62M
56.66M
56.66M
$-1.83
$-1.83
Balance Sheet Financials
$474.88M
$0.03M
$1.29M
$476.17M
$16.57M
--
--
$16.57M
$459.60M
$459.60M
$459.60M
59.44M
Cash Flow Statement Financials
$-70.30M
$-173.84M
$218.87M
$124.17M
$98.90M
$-25.27M
$34.02M
--
--
Fundamental Metrics & Ratios
28.66
--
--
--
--
--
--
--
--
--
--
$-70.25M
--
--
--
--
--
Receiveable Turnover
--
--
-22.56%
-22.56%
-21.78%
-22.56%
$7.73
$-1.24
$-1.24